11,630,000 Shares in Surgery Partners, Inc. $SGRY Acquired by Pentwater Capital Management LP

Pentwater Capital Management LP acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) in the second quarter, Holdings Channel reports. The fund acquired 11,630,000 shares of the company’s stock, valued at approximately $195,384,000. Surgery Partners comprises 1.2% of Pentwater Capital Management LP’s investment portfolio, making the stock its 17th biggest position. Pentwater Capital Management LP owned approximately 0.09% of Surgery Partners as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. PNC Financial Services Group Inc. grew its position in Surgery Partners by 239.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after purchasing an additional 2,051 shares during the period. Fifth Third Bancorp raised its holdings in shares of Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after acquiring an additional 3,993 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Surgery Partners by 45,640.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after acquiring an additional 2,282 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in Surgery Partners during the 3rd quarter valued at about $121,000. Finally, Alpine Global Management LLC bought a new stake in Surgery Partners during the 4th quarter worth approximately $175,000.

Surgery Partners Price Performance

SGRY opened at $14.04 on Thursday. Surgery Partners, Inc. has a twelve month low of $11.41 and a twelve month high of $23.44. The company has a market capitalization of $1.84 billion, a price-to-earnings ratio of -20.06, a PEG ratio of 3.81 and a beta of 1.91. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The firm has a 50-day moving average price of $15.52 and a 200-day moving average price of $14.39.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. The firm had revenue of $848.90 million for the quarter, compared to the consensus estimate of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.17 earnings per share. Equities analysts expect that Surgery Partners, Inc. will post 0.25 EPS for the current year.

Insider Buying and Selling

In other news, Director Teresa Deluca purchased 10,000 shares of Surgery Partners stock in a transaction dated Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the transaction, the director directly owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently weighed in on SGRY. Cantor Fitzgerald restated an “overweight” rating and issued a $18.00 target price on shares of Surgery Partners in a report on Tuesday, August 11th. Benchmark restated a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Jefferies Financial Group reiterated a “buy” rating and issued a $17.00 target price on shares of Surgery Partners in a research note on Wednesday, May 6th. Raymond James Financial set a $18.00 target price on shares of Surgery Partners in a report on Tuesday, August 11th. Finally, TD Cowen boosted their price target on shares of Surgery Partners from $17.00 to $19.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Surgery Partners presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.45.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.